Latest glioblastoma multiforme Stories
SAN ANTONIO, June 19, 2014 /PRNewswire/ -- GenSpera, Inc.
New research report “Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany” elaborated
American Brain Tumor Association’s Team Breakthrough Racing; Raising Funds to Advance the Understanding and Treatment of Brain Tumors (PRWEB) June 17, 2014
Neurosurgeon Peter Nakaji has published four academic papers with colleagues, each discussing technology and the intraoperative diagnosis of brain tumors. Phoenix,
SAN DIEGO, June 17, 2014 /PRNewswire/ -- DNAtrix, Inc., experts in oncolytic virus development, today announced that the U.S.
Companies expect to commence first-in-human studies of Trx-1 in ovarian cancer in 1H15 BOSTON, June 17, 2014 /PRNewswire/ -- Australian oncology drug development company Novogen
Scientists from the Broad Institute and Massachusetts General Hospital (MGH) have conducted a first-of-its-kind study that characterizes the cellular diversity within glioblastoma tumors from patients.
Analysis of PRiDe, a U.S.
All 9 Out Of 9 Patients Who Have Reached 4 Injections Are Showing Tumor Cell Death, Tumor Shrinkage And/Or Stabilization Of Disease BETHESDA, Md., June 11, 2014 /PRNewswire/
LONDON, June 10, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: